Delta Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$432K Hold
4,047
0.1% 147
2024
Q4
$374K Buy
+4,047
New +$364K 0.09% 163
2024
Q2
Sell
-4,066
Closed -$298K 154
2024
Q1
$298K Sell
4,066
-187
-4% -$14.4K 0.09% 181
2023
Q4
$345K Sell
4,253
-509
-11% -$39.6K 0.11% 142
2023
Q3
$357K Buy
+4,762
New +$366K 0.12% 128
2023
Q2
Sell
-2,912
Closed -$242K 126
2023
Q1
$242K Buy
2,912
+6
+0.2% +$497 0.1% 149
2022
Q4
$247K Buy
+2,906
New +$230K 0.11% 139

Other funds holding GILD

Delta Financial Group's GILD Position: Q1 2025 in Review

Delta Financial Group held its Gilead Sciences (GILD) position steady in Q1 2025 at 4,047 shares worth $432K. The position accounts for 0.1% of the portfolio, ranked #147.

Delta Financial Group first reported a position in GILD in Q4 2022 and has held it in 7 quarters since. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Delta Financial Group held 4,047 shares of Gilead Sciences worth $432K as of Q1 2025.
  • Delta Financial Group left its Gilead Sciences share count unchanged in Q1 2025.
  • Gilead Sciences made up 0.1% of Delta Financial Group's portfolio in Q1 2025, its #147 holding.
  • Delta Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 7 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.